Angeion Corporation Awarded National Contract by
June 30, 2010 09:03 AM Eastern Daylight Time
SAINT PAUL, Minn.--(EON: Enhanced Online News)--Angeion Corporation (NASDAQ: ANGN) announced
that it has been awarded a three-year contract with Amerinet – a leading national healthcare group purchasing
organization – for its MedGraphics® cardiorespiratory diagnostic systems. The agreement is effective July 1, 2010.
It offers Amerinet members and partners access to MedGraphic’s systems that diagnose and monitor therapy in a
wide spectrum of heart and lung disorders, such as congestive heart failure, asthma and other forms of chronic
obstructive pulmonary disease (COPD).
Amerinet has more than 2,500 acute care hospitals and 25,000 alternate care members in its network of healthcare
providers. With MedGraphic’s full clinical product line, Amerinet customers will be able to: offer simple
spirometry—or breath measurement—in clinics and physician offices; complete pulmonary function testing in hospital
laboratories; assess cardiopulmonary exercise in rehabilitation and sports medicine centers; and provide nutritional
evaluations in critical care units.
“We are pleased that Amerinet, one of the nation’s largest group purchasing organizations, recognizes the diagnostic
value that our MedGraphic’s systems can provide to the patients and physicians in their network,” said Rodney A.
Young, Angeion’s President and Chief Executive Officer. “We share Amerinet’s goal of providing high quality care
and reducing costs across the entire continuum of health.”
MedGraphic’s technologies provide clinical professionals with essential information to noninvasively assess and
successfully manage their patients’ care. These cardiorespiratory diagnostic products are used in leading medical
centers throughout the United States and in more than 75 countries around the world.
As a leading national healthcare group purchasing organization, Amerinet strategically partners with acute and